Dermatosis Neglecta or Terra Firma-Forme Dermatosis.

lesions occurred in up to a third of patients who initially responded to alitretinoin after 24 weeks of follow-up. A recent study reported that a second course of treatment with alitretinoin at a dosage of 30mg/d in patients who relapsed achieved clearance in up to 80% of cases, with good tolerance; this would indicate that this medication could be used for long-term management of chronic hand eczema. Alitretinoin is therefore a useful and probably cost-effective treatment for this condition. We have presented the case of a patient with chronic foot eczema that did not respond to various traditional treatments. Alitretinoin achieved complete clearance of the eczema. Alitretinoin could be a useful alternative for the management of patients with chronic foot eczema.